$ Value
$0
Shares
574,385
Price
$0
Filed
Mar 24
Insider
Name
Dunlap Ryan
Title
—
CIK
0001554742
Roles
Transaction Details
Transaction Date
2026-03-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
574,385
Footnotes
This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). | The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.
Filing Info
Dunlap Ryan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-20 | CYDY | A | $0 |
Other Insiders at CYDY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SIMES STEPHEN M | — | — | 2026-03-20 |
|
Hoffman Robert E.
Chief Financial Officer
|
— | — | 2026-03-20 |
| Urbach Tanya Durkee | — | — | 2026-03-20 |
| Ndhlovu Lishomwa C | — | — | 2026-03-20 |
| Brunke Karen J | — | — | 2026-03-20 |
|
Blok Tyler
Chief Legal Officer
|
— | — | 2026-03-20 |
|
Lalezari Jacob P
Chief Executive Officer
|
— | — | 2026-03-20 |